痛风性关节炎辨证因子的分级量化研究Grading Quantification Study about Syndrome Differentiation Factor of Gouty Arthritis
甘建平,李延萍,吴斌
摘要(Abstract):
痛风性关节炎是一种好发于中青年的代谢性疾病,尽管中医药防治经验丰富,但目前其中医评价体系还不完善,缺乏规范的辨证因子分级量化标准,导致痛风病情和疗效难以评估。本文从分级量化的现状、辨证因子的筛选、评分细则的制定原则3个方面论述,从主症、次症的角度确定了该病的22个辨证因子,并制定出轻、中、重度3个等级的评分细则,以期为痛风的病情评估和疗效评价提供初步参考。
关键词(KeyWords): 痛风;辨证因子;分级量化;评分细则
基金项目(Foundation): 重庆市科委科技项目(cstc2015shmszx120105,cstc2014ptgc1003;cstc2016shmszd10001)
作者(Author): 甘建平,李延萍,吴斌
参考文献(References):
- [1]Xie Z,Wu H,Jing X,et al.Hypouricemic and arthritis relapsereducing effects of compound tufuling oral-liquid in intercritical and chronic gout:A double-blind,placebocontrolled,multicenter randomized trial[J].Clinical Trial/Experimental Study,2017,96(11):e6315.
- [2]甘建平,朱丰林,李延萍,等.清热利湿法治疗急性痛风性关节炎临床疗效的Meta分析[J].风湿病与关节炎,2016,9(5):28-33.
- [3]国家中医药管理局.中医病证诊断疗效标准[M].北京:中国医药科技出版社,2012:50-51.
- [4]国家中医药管理局.22个专业95个病种中医诊疗方案[M].北京:中国中医药出版社,2010:238-270.
- [5]王义军.痛风性关节炎的辨证论治[J].中医药导报,2015,21(3):89-90.
- [6]刘湘玲,韩德军,杨锡燕.当代名老中医治疗急性痛风性关节炎经验用药规律[J].中国实验方剂学杂志,2017,23(2):187-192.
- [7]中华人民共和国卫生部.中药新药临床研究指导原则[M].北京:中国医药科技出版社,1995:180.
- [8]李炜弘,严石林,高泓,等.81项辨证因子归纳及其在糖尿病辨证中的应用[J].中国中医药信息杂志,2006,13(11):89-91.
- [9]宋敬锋,刘昊,张岩,等.祛风通络利湿中药治疗湿热痹阻证痛风性关节炎疗效及对MMP-3、COX-2的影响[J].现代中西医结合杂志,2017,26(16):1741-1744.
- [10]肖伟,毛辉辉,张先进,等.新癀片外敷联合西药治疗痛风性关节炎的临床疗效观察[J].时珍国医国药,2017,5(28):1155-1156.
- [11]Xu S,Liu X,Ming J,et al.A phase 3,multicenter,randomized,allopurinol-controlled study assessing the safety and efficacy of oral febuxostat in Chinese gout patients with hyperuricemia[J].International Journal of Rheumatic Diseases,2015,18:669-678.
- [12]Yu KH,Lai JH,Hsu PN,et al.Safety and efficacy of oral febuxostat for treatment of HLA-B*5801-negative gout:a randomized,open-label,multicentre,allopurinol-controlled study[J].Scand J Rheumatol,2016,45(4):304-311.
- [13]Huang X,Du H,Gu J,et al.An allopurinol-controlled,multicenter,randomized,doubleblind,parallel between-group,comparative study of febuxostat in Chinese patients with gout and hyperuricemia[J].International Journal of Rheumatic Diseases,2014,17:679-686.
- [14]Wang Y,Wang L,Li E,et al.Chuanhu anti-gout mixture versus colchicine for acute gouty arthritis:a randomized,doubleblind,double-dummy,non-inferiority trial[J].Int J Med Sci,2014,11(9):880-885.
- [15]Jeffrey P,Alexandra S,Steinberg,et al.A randomized,Double-blind,active-and placebo-controlled efficacy and safety study of arhalofenate for reducing flare in patients with gout[J].Arthritis Rheumatol,2016,68(8):2027-2034.
- [16]张伯礼,薛博瑜.中医内科学[M].北京:人民卫生出版社,2012:334-340.
- [17]国家中医药管理局.中医临床诊疗术语:证候部分[M].北京:中国标准出版社,1997:8.
- [18]徐迪华,徐剑秋.中医量化诊断[M].南京:江苏科学技术出版社,1997:51.
- [19]由松.中医症状及证候的量化方法探讨[J].北京中医药大学学报,2002,25(2):13-15.
- [20]严石林,张连文,王米渠,等.肾虚证辨证因子等级评判操作标准的研究[J].成都中医药大学学报,2001,24(1):56-59.